
10.89 Delayed Data As of May 26 | ![]() Today’s Change | 9.83 Today|||52-Week Range 25.74 | -50.92% Year-to-Date |
The 7 analysts offering 12-month price forecasts for Avidity Biosciences Inc have a median target of 30.00, with a high estimate of 71.00 and a low estimate of 20.00. The median estimate represents a +175.48% increase from the last price of 10.89.
The current consensus among 8 polled investment analysts is to Buy stock in Avidity Biosciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.